- NEWS AND VIEWS
Two types of fibroblast drive arthritis
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Nature 570, 169-170 (2019)
Lynch, M. D. & Watt, F. M. J. Clin. Invest. 128, 26–35 (2018).
Malmström, V., Catrina, A. I. & Klareskog, L. Nature Rev. Immunol. 17, 60–75 (2017).
Croft, A. P. et al. Nature 570, 246–251 (2019).
Huelsken, J. & Hanahan, D. Cell 172, 643–644 (2018).
Roberts, E. W. et al. J. Exp. Med. 210, 1137–1151 (2013).
Vallejos, C. A., Risso, D., Scialdone, A., Dudoit, S. & Marioni, J. C. Nature Methods 14, 565–571 (2017).
Vannella, K. M. & Wynn, T. A. Annu. Rev. Physiol. 79, 593–617 (2017).
Loeser, R. F., Goldring, S. R., Scanzello, C. R. & Goldring, M. B. Arthritis Rheum. 64, 1697–1707 (2012).
T.A.W.’s employer Pfizer has approved products for rheumatoid arthritis.